Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
10/14/1993 | WO1993019747A1 Compounds useful for treating allergic and inflammatory diseases |
10/14/1993 | WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression |
10/14/1993 | WO1993015061A3 Method of preparing 2-arylbenzimidazole 5-sulphonic acids |
10/14/1993 | CA2133470A1 Medicament for the treatment of airways inflammation and airways hyperresponsiveness |
10/14/1993 | CA2132516A1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis |
10/13/1993 | EP0565450A1 Use of peptide derivatives for the manufacture of medicaments inhibiting endopeptidases 24.15 and 24.16 |
10/13/1993 | EP0565241A1 Oligosaccharides |
10/13/1993 | EP0565185A1 Quinoline derivatives as leukotriene antagonists |
10/13/1993 | EP0565135A1 Known and selected novel arylmethylenyl derivatives of imidazolidinones useful as antiallergy agents and antiinflammatory agents |
10/13/1993 | EP0564924A2 2-Oxoethyl derivatives as immunosuppressants |
10/13/1993 | EP0564835A2 2,2-Disubstituted cephem sulphones |
10/13/1993 | EP0564805A1 (4-benzylphthalazin-1(2H)-on-2-yl)aminocarboxylic acids having antiallergic/antihistaminic activity and process for their production |
10/13/1993 | EP0564739A2 Backbone cyclic peptides, processes for their preparation and pharmaceutical compositions containing them |
10/13/1993 | EP0564561A1 Peptides ketoamides, ketoacids, and ketoesters |
10/13/1993 | CN1077198A Anti-proliferative and anti-inflammatory compounds:5-or 6-deoxy hexose monosacchardies having a saturated nitrogen containing heterocycle at the 5-or 6-position bound through the nitrogen atom |
10/12/1993 | US5252560 Cyclic imide derivatives, compositions and use |
10/09/1993 | CA2091194A1 2-oxo-ethyl derivatives as immunosuppressants |
10/06/1993 | EP0563286A1 Novel csaids |
10/06/1993 | EP0563239A1 A truncated interleukin-1 receptor gene for the treatment of arthritis |
10/06/1993 | EP0563128A1 New 3,4-dihydroisoquinoline derivates and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines |
10/06/1993 | EP0563042A1 Radionuclide labelled particles useful for radiation synovectomy |
10/06/1993 | CN1022324C Anhydrous crystal sodium salt of 5-chloro-3-(2-thenoyl)-2-oxyindole-1-carboxamide |
10/05/1993 | US5250678 For autoimmune, infectious diseases, organ transplant rejection; skin diseases, antiinflammatory agents |
10/05/1993 | US5250513 Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same |
09/30/1993 | WO1993019203A1 Oligonucleotide modulation of protein kinase c |
09/30/1993 | WO1993019068A1 PYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS |
09/30/1993 | WO1993019064A1 Quinuclidine derivatives as substance p antagonists |
09/30/1993 | WO1993019044A1 Novel vitamin d analogues |
09/30/1993 | WO1993019024A2 Mercapto-acetamide derivatives |
09/30/1993 | WO1993018782A1 Glycosylation-mediated inhibition of factor x |
09/30/1993 | WO1993013117A3 5- or 6-aminodeoxyfuranoside derivatives with antiinflammatory and antiproliferative activity |
09/30/1993 | WO1993012814A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
09/30/1993 | CA2132518A1 Glycosylation-mediated inhibition of factor x |
09/30/1993 | CA2132094A1 Oligonucleotide modulation of protein kinase c |
09/30/1993 | CA2120703A1 Novel vitamin d analogues |
09/29/1993 | EP0562439A1 Triazolopyridazines as antioasthmatics |
09/29/1993 | EP0561948A1 Phosphonic acid derivatives useful as antiinflammatory agents. |
09/29/1993 | EP0561772A1 A new pharmaceutical use of fusidic acid and derivatives thereof |
09/29/1993 | CN1076696A Pharmaceutical compounds |
09/29/1993 | CN1022241C Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
09/28/1993 | US5248695 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in animal feeds |
09/28/1993 | US5248693 Acetylene compounds and pharmaceutical compositions and methods of using the same |
09/28/1993 | US5248685 5-lipoxygenase inhibitor |
09/28/1993 | US5248681 Antiinflammatory agents |
09/28/1993 | US5248680 Zwitterionic compounds and their n-halo derivatives for use in the treatment of clinical conditions |
09/28/1993 | CA1322531C Phenolic thioethers as inhibitors of 5-lipoxygenase |
09/22/1993 | EP0561523A2 Sugar compound, sialic acid-containing sugar chains' biosynthesis inhibitor, production process thereof and intermediate |
09/22/1993 | EP0561237A2 Enantiomer, (-)-N-(2-ethoxyphenyl)-N'-(1,2,2-trimethylpropyl)-2-nitromethene-1,1-diamine, process for its preparation and its use |
09/22/1993 | EP0560929A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity |
09/22/1993 | EP0560900A1 Prevention of synovial adhesions. |
09/22/1993 | EP0560809A1 Agent for reducing the growth of, or removing, human body hair. |
09/22/1993 | EP0560806A1 Anti-inflammatory composition derived from emu oil |
09/22/1993 | EP0477178B1 Therapeutic composition and kit for the treatment of rhumatoid polyarthritis |
09/22/1993 | EP0474712B1 Lysolecithin derivatives for treating autoimmune diseases |
09/22/1993 | CN1076453A Novel cyclosporins |
09/21/1993 | US5246966 Substituted alkenoic acid and its derivatives |
09/21/1993 | US5246951 Nonsteroidal antiinflammatory agents |
09/21/1993 | CA1322370C Phosphate ester derivatives, their preparation and their therapeutic use |
09/21/1993 | CA1322367C Thienotriazolodiazepine compounds and pharmaceutical uses thereof |
09/21/1993 | CA1322332C Protein c inhibitor (pci) as pharmaceutical and diagnostic aid a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci |
09/19/1993 | CA2091874A1 Triazolopyridazine compounds, their production and use |
09/19/1993 | CA2091634A1 Enantiomer (-)-n-(2-ethoxyphenyl)-n'- (1,2,2-trimethylpropyl)-2-nitroethene-1-, 1-diamine, process for the preparation thereof and the use thereof |
09/16/1993 | WO1993018141A1 Thrombin receptor antagonists |
09/16/1993 | WO1993018024A1 1-alkoxy-2-(alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
09/16/1993 | WO1993018002A1 Quaternary salts of 4-substituted piperidines, preparation thereof and pharmaceutical compositions containing same |
09/16/1993 | WO1993017713A1 Pharmaceutical composition having site-specific delivery |
09/16/1993 | WO1993017695A1 Diagnosis and treatment of various neuralgias |
09/16/1993 | WO1993017684A2 Enantiomeric hydroxylated xanthine compounds |
09/16/1993 | WO1993017677A1 Antipyretic and analgesic methods and compositions containing optically pure r(-) ketoprofen |
09/16/1993 | WO1993017655A1 Topical aromatic releasing compositions |
09/16/1993 | CA2131990A1 Pharmaceutical composition having site-specific delivery |
09/16/1993 | CA2131802A1 Antipyretic and analgesic methods and compositions containing optically pure r(-)ketoprofen |
09/16/1993 | CA2131389A1 Thrombin receptor antagonists |
09/16/1993 | CA2130938A1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
09/15/1993 | EP0560407A1 Pharmaceutically active compounds |
09/15/1993 | EP0560329A1 Pranoprofen-containing, suspending medicinal composition |
09/15/1993 | EP0559728A1 Aromatic aldehydes and derivatives and pharmaceutical compositions thereof useful for the treatment of skin diseases and arthritis |
09/15/1993 | CN1076186A Cryogenic rectification system with argon heat pump |
09/13/1993 | CA2091521A1 Method for producing carbohydrates |
09/11/1993 | CA2091399A1 Pranoprofen-containing, suspending medicinal composition |
09/08/1993 | EP0559538A1 Quaternary salts of 4-substituted piperidines, their preparation and pharmaceutical compositions containing them |
09/08/1993 | EP0558681A1 Treatment for tissue ulceration |
09/08/1993 | EP0558648A1 Improved matrix metalloprotease inhibitors |
09/08/1993 | EP0554291A4 Treatment of non-inflammatory and non-infectious bowel disorders |
09/08/1993 | CN1075959A Pyrazole derivatives processes for preparation thereof and pharmaceutical composition comprising the same |
09/08/1993 | CA2091105A1 Aminocarboxylic acid derivatives with antiallergic/antiasthmatic effect and a process for their preparation |
09/07/1993 | US5242945 Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors |
09/07/1993 | US5242930 Tachykinin antagonists; nervous system disorders, anxiolytic agents |
09/07/1993 | US5242929 Derivatives of substituted imidazol-2-one and process for their preparation |
09/07/1993 | US5242912 Cyclic anthranilic acid derivatives and process of preparing the same |
09/07/1993 | US5242691 Purified milk product from animal maintained in hyperimmunized state |
09/07/1993 | CA1322076C Phosphorus containing peptides |
09/07/1993 | CA1322074C Pharmaceutically useful derivatives of thiazolidine-4- carboxylic acid |
09/07/1993 | CA1322005C Benzoheterazoles |
09/04/1993 | CA2090785A1 Quaternary ammonium salts of aromatic amine compounds, their preparation and pharmaceutical compositions in which they are present |
09/02/1993 | WO1993017122A1 Protein with novel pharmacological characteristic |
09/02/1993 | WO1993017013A1 Quinolylbenzofuran derivatives as leukotriene antagonists |
09/02/1993 | WO1993017008A1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO[b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION |
09/02/1993 | WO1993016732A1 Formulations containing hyaluronic acid |
09/02/1993 | WO1993016724A1 Bystander suppression of autoimmune diseases |